Beurs.nl monitor iconMarkt Monitor
  • AEX +19,73 839,29 +2,41%
  • DE40 0,00 20.374,10 0,00%
  • US500^ +50,07 5.408,33 +0,93%
  • US30^ +342,80 40.556,80 +0,85%
  • EUR/USD +0,00 1,1350 +0,26%
  • WTI +0,19 61,67 +0,31%
  • Gold spot -26,52 3.210,95 -0,82%

VendexKBB Terug naar discussie overzicht

Belegger Vendex: opgelet.

1 Post
| Omlaag ↓
  1. Robin Good 5 februari 2004 22:14
    Trek zelf uw conclusies.

    Reuters
    UPDATE - Vendex approached about 1.3 bln euro buy-out offer
    Thursday February 5, 3:48 pm ET
    By Christopher Borowski

    (Adds key shareholder backing, Vendex spokesman)
    AMSTERDAM, Feb 5 (Reuters) - Several international private equity groups have approached Dutch retailer Vendex KBB (Amsterdam:VENDc.AS - News) about a possible 1.3 billion euros ($1.6 billion) buy-out offer, the company said on Thursday.

    ADVERTISEMENT


    Vendex, which has been under pressure to go private and shed unprofitable
    units, said it was in discussions about a potential offer of about 14 euros per share, a 22-percent premium over its Thursday closing price of 11.41 euros.

    Boston-based investment fund K Capital Partners, Vendex's biggest shareholder that has been looking for buyers over the last several months, said it backed the company's decision to enter buy-out talks.

    "Vendex shares are fundamentally undervalued and their price does not reflect the company's intristic value. Taking the company private is a fast and efficient way of releasing this value," Peter Manhout of Petercam, which advises K Capital, told Reuters.

    Vendex, which sells a wide range of products from drills to dresses and cutlery to computers, has been struggling to return to profit and has faced increased shareholder pressure.

    The buy-out proposal was preliminary and non-binding, Vendex KBB said, adding that it was unclear whether the exploratory discussions would lead to a public offer.

    Vendex spokesman Peter van Bakkum declined to name any of the potential buyers, but said they would start a due dilligence investigation next week and the process would last between six and eight weeks.

    "The supervisory board and management board have decided to explore the possibilities of effecting a transaction with a selected number of parties, who are interested in the group as a whole and endorse the corporate strategy," the firm said.

    "The process is still in an initial phase and is likely to take several months. Further information will follow if and when appropriate," it said.

    Last year K Capital, backed by U.S. corporate raider Guy Wyser-Pratte, sought to push Vendex management to shed loss-making units such as V&D and to take the company private.

    At the time, Vendex said it had no such disposal plans and would stick to its strategy to restructure and expand its profitable fashion outlets and do-it-yourself stores.

    In its statement released after Thursday's market close, Vendex also noted that expenditure in the non-food sector had remained under pressure in the fourth quarter, with apparel and consumer electronics markets showing a marked decline.

    The company said its troubled V&D department stores would post a full-year loss of between 30 million and 50 million euros, in line with earlier forecasts, and it would take an 80 million euros restructuring charge for the unit. (Additional reporting by Theo Kolker and Melanie Cheary)

    __________________________________________________________________________

    Reuters
    Key Vendex shareholder backs buy-out talks
    Thursday February 5, 2:39 pm ET

    AMSTERDAM, Feb 5 (Reuters) - K Capital Partners, a key shareholder of Dutch retailer Vendex KBB (Amsterdam:VENDc.AS - News), said on Thursday it backs the company's decision to enter talks with private equity groups about a possible 1.3 billion euros ($1.6 billion) buy-out offer.
    "Today's decision to pursue a competitive process to explore the possibility of a transaction is exactly the type of action that is in the best interests of all shareholders, " K Capital said in a statement.

    Vendex spokesman Peter van Bakkum said the potential buyers would start a due diligence investigation next week and the process would last between six and eight weeks.

    Last Trade: 11.41
    Trade Time: 11:32AM ET
    Change: 0.03 (0.26%)
    Prev Close: 11.38
    Open: 11.21
    Bid: 11.40
    Ask: 11.46
    1y Target Est: N/A

    Day's Range: 11.21 - 11.50
    52wk Range: 6.02 - 12.00
    Volume: 221,380
    Avg Vol (3m): 0
    Market Cap: 0
    P/E (ttm): 0.00
    EPS (ttm): N/A
    Div & Yield: 0.43 (3.78%)



1 Post
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.172
AB InBev 2 5.546
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.522
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.931
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 193
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.893
Aedifica 3 927
Aegon 3.258 323.215
AFC Ajax 538 7.093
Affimed NV 2 6.307
ageas 5.844 109.914
Agfa-Gevaert 14 2.075
Ahold 3.538 74.363
Air France - KLM 1.025 35.336
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.075
Alfen 16 25.511
Allfunds Group 4 1.525
Almunda Professionals (vh Novisource) 651 4.254
Alpha Pro Tech 1 17
Alphabet Inc. 1 427
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 244.287
AMG 972 134.796
AMS 3 73
Amsterdam Commodities 305 6.757
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 501
Antonov 22.632 153.605
Aperam 92 15.112
Apollo Alternative Assets 1 17
Apple 5 387
Arcadis 252 8.808
Arcelor Mittal 2.035 321.105
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.382
Aroundtown SA 1 221
Arrowhead Research 5 9.759
Ascencio 1 30
ASIT biotech 2 697
ASMI 4.108 39.705
ASML 1.767 112.475
ASR Nederland 21 4.522
ATAI Life Sciences 1 7
Atenor Group 1 523
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 14.363
Axsome Therapeutics 1 177
Azelis Group 1 69
Azerion 7 3.463